Vascular system-peripheral arteries, percutaneous approach

85816100 Category Share

Vascular system-peripheral arteries, percutaneous approach is an EFRIS commodity class (code 85816100) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

33 items in this category

• 85816113Introduction of analgesics, hypnotics, sedatives into peripheral artery, percutaneous approach
  Exempt
• 85816122Introduction of anti-inflammatory into peripheral artery, percutaneous approach
  Exempt
• 85816105Introduction of anti-inflammatory into peripheral nerves and plexi, percutaneous approach
  Exempt
• 85816111Introduction of antiarrhythmic into peripheral artery, percutaneous approach
  Exempt
• 85816116Introduction of blood brain barrier disruption substance into peripheral artery, percutaneous approach
  Exempt
• 85816126Introduction of clofarabine into peripheral artery, percutaneous approach
  Exempt
• 85816110Introduction of destructive agent into peripheral artery, percutaneous approach
  Exempt
• 85816101Introduction of destructive agent into peripheral nerves and plexi, percutaneous approach
  Exempt
• 85816119Introduction of electrolytic and water balance substance into peripheral artery, percutaneous approach
  Exempt
• 85816130Introduction of high-dose interleukin-2 into peripheral artery, percutaneous approach
  Exempt
• 85816108Introduction of human b-type natriuretic peptide into peripheral artery, percutaneous approach
  Exempt
• 85816132Introduction of immunostimulator into peripheral artery, percutaneous approach
  Exempt
• 85816131Introduction of immunosuppressive into peripheral artery, percutaneous approach
  Exempt
• 85816109Introduction of insulin into peripheral artery, percutaneous approach
  Exempt
• 85816118Introduction of intracirculatory anesthetic into peripheral artery, percutaneous approach
  Exempt
• 85816104Introduction of local anesthetic into peripheral nerves and plexi, percutaneous approach
  Exempt
• 85816129Introduction of low-dose interleukin-2 into peripheral artery, percutaneous approach
  Exempt
• 85816127Introduction of monoclonal antibody into peripheral artery, percutaneous approach
  Exempt
• 85816120Introduction of nutritional substance into peripheral artery, percutaneous approach
  Exempt
• 85816123Introduction of other anti-infective into peripheral artery, percutaneous approach
  Exempt
• 85816128Introduction of other antineoplastic into peripheral artery, percutaneous approach
  Exempt
• 85816114Introduction of other diagnostic substance into peripheral artery, percutaneous approach
  Exempt
• 85816107Introduction of other hormone into peripheral artery, percutaneous approach
  Exempt
• 85816117Introduction of other therapeutic substance into peripheral artery, percutaneous approach
  Exempt
• 85816102Introduction of other therapeutic substance into peripheral nerves and plexi, percutaneous approach
  Exempt
• 85816125Introduction of other thrombolytic into peripheral artery, percutaneous approach
  Exempt
• 85816124Introduction of oxazolidinones into peripheral artery, percutaneous approach
  Exempt
• 85816112Introduction of platelet inhibitor into peripheral artery, percutaneous approach
  Exempt
• 85816115Introduction of radioactive substance into peripheral artery, percutaneous approach
  Exempt
• 85816133Introduction of recombinant human-activated protein c into peripheral artery, percutaneous approach
  Exempt
• 85816103Introduction of regional anesthetic into peripheral nerves and plexi, percutaneous approach
  Exempt
• 85816121Introduction of serum, toxoid and vaccine into peripheral artery, percutaneous approach
  Exempt
• 85816106Introduction of vasopressor into peripheral artery, percutaneous approach
  Exempt